Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Ingrezza	2.35B	2.31B	2.20B	2.07B	1.93B	1.84B	1.74B	1.63B
Ingrezza Growth	21.80%	26.00%	26.72%	27.42%	25.79%	28.59%	30.49%	31.14%
Collaboration and Other	27.30M	24.70M	26.20M	27.70M	27.70M	26.50M	25.90M	27.50M
Collaboration and Other Growth	-1.44%	-6.79%	1.16%	0.73%	-41.44%	-44.56%	-47.03%	-42.11%
Ongentys and Other Products	18.20M	17.20M	18.00M	20.40M	22.70M	24.60M	23.00M	19.80M
Ongentys and Other Products Growth	-19.82%	-30.08%	-21.74%	3.03%	45.51%	87.79%	125.49%	106.25%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.